secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001437749-24-001581
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology presents at B. Riley Oncology Conference; no material new information disclosed.
--------------------------------------------------------------------------------

- Presentation at B. Riley Securities 4th Annual Oncology Conference on January 18, 2024.
- Chairman, President and CEO Alan H. Auerbach to present.
- Exhibit 99.1 presentation not included as extractable text; specifics unavailable.
- No financial or operational updates disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774924001581/0001437749-24-001581-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774924001581/pbyi20240116_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001581

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer